Building a future where biology is design
Founded in late 2023, Somite AI developed an AI platform called AlphaStem targeting cell therapy and drug development. In 2026 the company rebranded as Cellular Intelligence, building the first universal virtual cell-signaling model to decode and control cellular behavior. Backed by Khosla Ventures, Chan Zuckerberg Initiative, and AMD Ventures, the company has raised over $100M with scientific co-founders from Harvard Medical School and MIT.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMay 2025
Apr 2024
Create a free account to see which investors have funded this company.
Create Free Account
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
